Based on SEC filing data. A pharmaceutical corporation founded in 2012 and based in New York raised $2.5M through a Series A convertible note. The company operates in the pharma sector.
Get notified the moment Axsome Therapeutics, Inc. (AXSM) files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.